Bullous autoimmune dermatoses. Part 3: Diagnosis and therapy;Bullöse autoimmundermatosen. Teil 3: Diagnostik und therapie

Hautarzt

Volumn 53, Issue 5, 2002, Pages 352-366

  Hertl, M ^a   Schuler, G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; GLUCOCORTICOID; GLUTEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PREDNISONE; TETRACYCLINE;

AGRANULOCYTOSIS; ALOPECIA; ANAPHYLAXIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL INFECTION; BULLOUS SKIN DISEASE; CATARACT; CONVULSION; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHING SYNDROME; DIABETES MELLITUS; DIARRHEA; DIET RESTRICTION; DIFFERENTIAL DIAGNOSIS; DRUG FEVER; DRUG HYPERSENSITIVITY; EPIDERMOLYSIS BULLOSA ACQUISITA; EXFOLIATIVE DERMATITIS; GLAUCOMA; HEADACHE; HEMOLYTIC ANEMIA; HEMORRHAGIC CYSTITIS; HISTOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; INFERTILITY; KIDNEY DISEASE; LIVER TOXICITY; METHEMOGLOBINEMIA; NAUSEA; NEPHROTOXICITY; NEUROPATHY; OPPORTUNISTIC INFECTION; PANCYTOPENIA; PEMPHIGOID; PEMPHIGUS VULGARIS; PLASMAPHERESIS; RASH; REVIEW; SEROLOGY; SKIN DISEASE; STOMATITIS; TERATOGENICITY; VIRUS INFECTION;

EID: 0036939416     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-002-0369-1     Document Type: Review

References (43)

1. Aberer W, Wolff-Schreiner FC, Stingl G, Wolff K (1987) Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol. 16:S27-S33
2. Ahmed AR, Hombal S (1987) Use of cyclophosphamide in azathioprine failures in pemphigus. J Am Acad Dermatol 17:437-442
3. Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimito K, Yamada T, Kitajima Y, Ohya K, Iwanami H, Nishikawa T (1999) Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 140:351-357
4. Anhalt GJ, Kim S, Stanley JR (1990) Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323:1729-1735
5. Blaszczyk M, Chorzelski T, Daszynski J, Gaczkowski A, Jablonska S, Beutner EH (1981) Plasmapheresis as a supplementary treatment in pemphigus. Arch Immunol Ther Exp 29(6):763-7
6. Bbhm M, Beissert S, Schwarz T, Metze D, Luger TA (1997) Bullous pemphigoid treate with mycophenolare mofetil. Lancet 349:541
7. Borradori L, Lombardi T, Samson J, Girardet C, Saurat JH, Hugli A (2001) Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 137:269-72
8. Bystryn JC, Steinman NM (1996) The adjuvant therapy of pemphigus. An update. Arch Dermatol 132:203-212
9. Chen M, Chan LS, Cai X, O'Toole EA, Sample JC, Woodley DT (1997) Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 108:68-72
10. Chorzelski TP, Sulej J, Tchorzewska H, Jablonska S, Beutner EH, Kumar V (1983) IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 4:325-334
11. Crow LL, Finkle JP, Gammon WR, Woodley DT (1988) Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 19:937-942
12. Cunningham BB, Kirchmann TT, Woodley DT (1996) Colchicine for epidermolysis bullosa (EBA). J Am Acad Dermatol 34:781-784
13. Dieterich W, Laag E, Bruckner-Tuderman L, Reunala T, Karpati S, Zagoni T, Riecken EO, Schuppan D (1999) Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 113:133-136
14. Egan CA, Lazarowa Z, Darling TN, Yee C, Coté T, Yancey K (2001) Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357:1850-1851
15. Enk AH, Knop J (1999) Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 135:54-56
16. Fine JD, Eady RAJ, Bauer EA, Briggaman RA, Bruckner-Tuderman L, Christiano A, Heagerty A, Hintner H, Jonkman M, McGrath J, McGuire J, Moshell A, Shimizu H, Tadini G, Uitto J (2000) Revised classification system for inherited epidermolysis bullosa: report of the second international consensus meeting on diagnosis and classification of epidermolyxsis bullosa. J Am Acad Dermatol 42:1051-1066
17. Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim D (1994) Nicotinamide and tetracycline therapy of bullous pemphigoid. Arch Dermatol 130:753-758
18. Fry L, Leonhard JN, Swain F et al (1982) Longterm follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 107:631-640
19. Gammon WR, Fine JD, Forbes M, Briggaman RA (1992) Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol.27:79-87
20. Gammon WR, Briggaman RA (1993) Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin 11:535-547
21. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA (1993) Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 151:5742-5750
22. Haase C, Büdinger L, Borradori L, Yee C, Merk HF, Yancey K, Hertl M (1998) Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2. J Invest Dermatol 110:282-286
23. Hashimoto T. (2001) Immunopathology of paraneoplastic pemphigus. Clin Dermatol 19:675-682
24. Hashimoto T. (2001) Immunopathology of IgA pemphigus. Clin Dermatol 19:683-689
25. Heilborn JD, Stahle-Backdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E (1999) Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.J Am Acad Dermatol 40:741-749
26. Ioannides D, Chrysomallis F, Bystryn JC (2000) Ineffectiveness of cyclosporine as adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol 136:868-872
27. Jackson AP, Hall AG, McLelland J (1997) Thiopurine methyltransferase levels should be measured before commencing patients on azathioprine. Br J Dermatol 136:133-134
28. Jolles S (2001) A review of high-dose intravenous immunoglobulin (hdlVIg) in the treatment of autoimmune blistering disorders. Clin Dermatol 26:127-131
29. Joly P, Picard C, Roujeau JC et al. et le groupe "bulles" (2000) Comparison de deux strategies therapeut iques: corticotherapie locale versus corticotherapie generale dans le traitement de la pemphigoide bulleuse. Ann Dermatol Venereol 127:4S4S1-74
30. Kadunce DP, McMurry MP, Avots-Avotins A, Chandler JP, Meyer LJ, Zone JJ (1991) The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis. J Invest Dermatol 97:175-182
31. Mahoney MG, Wang Z, Rothenberger KL, Koch PJ, Amagai M, Stanley JR (1999) Explanation for localization of blisters in pemphigus patients. J Clin Invest 103:461-468
32. Mascaro JM, Lecha M, Mascaro JM (1995) Fetal morbidity in herpes gestationis. Arch Dermatol 131:1209-1210
33. Milligan A, Hutchinson PE (1990) The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acd Dermatol 22:796-801
34. Nousari HC, Brodsky RA, Jones RJ, Grever MR, Anhalt GJ (1999) Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus. J Am Acad Dermatol 40:750-754
35. Nousari HC, Deterding R, Wojtczak H, Anhalt GJ (1999) The mechanisms of respiratory failure in paraneoplastic pemphigus. N Engl J Med 323:1729-1735
36. Pasricha JS, Thanzama J, Khan UK (1988) Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol 119:73-77
37. Rogers RS, Seehafer JR, Perry HO (1982) Treatment of cicatricial pemphigoid with dapsone. J Am Acad Dermatol 6:215-223
38. Späth S, Riechers R, Borradori L, Zillikens D, Büdinger L, Hertl M (2001) Detection of autoantibodies of various subclasses (IgG1, IgG4, IgA, IgE) against desmoglein 3 in patients with acute onset and chronic pemphigus vulgaris. Br J Dermatol 144:1183-1188
39. Toth GG, Jonkman MF (2001) Therapy of pemphigus. Clin Dermatol 19:761-767
40. Vaughan Jones SA, Palmer I, Bhogal BS et al (1995) The use of Michel's transport media for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. J Cutan Pathol 22:365-370
41. Venning VA, Wojnarowska F (1990) The association of bullous pemphigoid and malignant disease: a case control study. Br J Dermatol 123:439-445
42. Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ (1997) Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 109:573-579
43. Zimmermann R, Faure M, Claudy A. (1999) Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid. Ann Dermatol Venereol 141:755-756